The global enzyme replacement therapy market is witnessing growth as enzyme-based treatments remain an important therapeutic approach for managing certain rare and inherited disorders. The market was valued at US$ 9,673.39 million in 2021 and is projected to reach US$ 15,184.70 million by 2028. The market is estimated to grow at a compound annual growth rate of 6.8% from 2022 to 2028,...